Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$514,041
-$53,272 QoQ
Shares Held
3,280
-11.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#875
of 1,603 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AlTi Global, Inc. holds $38,982,569 across 10 Drug Manufacturers - General names. NVS ranks #9 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
55,639 | $14,130,636 | |
| 2 | AMGN |
Amgen Inc
|
22,182 | $8,032,544 | |
| 3 | LLY |
ELI LILLY & Co
|
5,208 | $6,246,631 | |
| 4 | ABBV |
AbbVie Inc.
|
17,917 | $4,508,632 | |
| 5 | MRK |
Merck & Co., Inc.
|
24,188 | $3,108,157 | |
| 6 | PFE |
Pfizer Inc
|
39,055 | $940,444 | |
| 7 | AZN |
Astrazeneca PLC
|
3,371 | $639,208 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
9,482 | $546,352 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $514,041 | 3,280 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $567,313 | 3,714 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $604,008 | 4,381 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $561,562 | 4,379 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $534,743 | 4,419 | Shares | Defined | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||